DOSIERFORMEN FÜR ARZNEIMITTEL

European patent · EP3079667 · In force

Register entry

Publication number
EP3079667
Application number
EP14819084
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 11, 2014
Published
Oct 19, 2016
Granted
Jun 26, 2019
Protection ends at the latest
Dec 10, 2034
Next annual fee due
Dec 31, 2026
IPC classes
A61K 9/16 (2006.01)
A61K 9/48 (2006.01)
A61K 31/506 (2006.01)
Priority
US 201361915606 P 13.12.2013
PCT application
PCT/IB2014/066820 11.12.2014
PCT publication
WO2015/087283 18.06.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 8, 2025

    Change

    Published in Swissreg on 08.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 10, 2023

    Change

    Published in Swissreg on 10.01.2023

  5. Jun 26, 2019

    Granted

    Published in Swissreg on 26.06.2019

Parties

Holder

Novartis AG

Lichtstrasse 35, 4056 Basel

Inventor

RIBEIRO, Suzie

4002 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.